
FDA Reverses Course, Agrees to Review Moderna's Flu Vaccine Application
The U.S. Food and Drug Administration has reversed its earlier decision and will now review Moderna's application for its modified influenza vaccine.
18 Feb, 12:07 — 18 Feb, 13:56
Perspective Analysis
Comparing sources…
Coverage Timeline
US FDA reverses course, will review Moderna's modified flu vaccine application - Reuters
Moderna gains as FDA backtracks and accepts flu shot for review
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive
Read at source (4 outlets)
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.
Read full article →F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
By Christina Jewett and Rebecca Robbins
Read full article →Moderna gains as FDA backtracks and accepts flu shot for review
Read full article →US FDA reverses course, will review Moderna's modified flu vaccine application - Reuters
US FDA reverses course, will review Moderna's modified flu vaccine application Reuters
Read full article →